RETA | Reata Pharmaceuticals, Inc. | 11273.7% | 2885% |
BNTX | BioNTech SE | 698.7% | 39% |
MRNA | Moderna, Inc. | 512.8% | 1.7% |
MDGL | Madrigal Pharmaceuticals, Inc. | 324.8% | 轉虧為盈% |
ITCI | Intra-Cellular Therapies, Inc. | 96.1% | 39.2% |
IMGN | ImmunoGen, Inc. | 68.1% | 637.7% |
PFE | Pfizer Inc. | 32.7% | 33.8% |
HALO | Halozyme Therapeutics, Inc. | 32.2% | 34.3% |
SRPT | Sarepta Therapeutics, Inc. | 28.9% | 40.8% |
ASND | Ascendis Pharma A/S | 28.4% | 20.4% |
GMAB | Genmab A/S | 23.5% | 16.8% |
CYTK | Cytokinetics, Incorporated | 22.4% | 22.5% |
OSH | Oak Street Health, Inc. | 19.8% | 46.4% |
MCK | McKesson Corporation | 15.7% | 21.3% |
INCY | Incyte Corporation | 13% | 23.8% |
CORT | Corcept Therapeutics Incorporated | 12.3% | 47.7% |
WST | West Pharmaceutical Services, Inc. | 11.6% | -0.1% |
SNY | Sanofi | 10.7% | 11.5% |
HQY | HealthEquity, Inc. | 10.6% | 23.1% |
CI | Cigna Corporation | 10.2% | 29.9% |
SNN | Smith & Nephew plc | 10.1% | 8.7% |
BMRN | BioMarin Pharmaceutical Inc. | 8.6% | 25.2% |
SWAV | ShockWave Medical, Inc. | 8.5% | 35.8% |
RMD | ResMed Inc. | 8.4% | 27.2% |
NVS | Novartis AG | 8.1% | 8.9% |
REGN | Regeneron Pharmaceuticals, Inc. | 8% | 10.6% |
CNC | Centene Corporation | 7.9% | 10.5% |
RGEN | Repligen Corporation | 7.7% | 9.7% |
NTRA | Natera, Inc. | 6.5% | 63.9% |
MASI | Masimo Corporation | 6.4% | 5.4% |
BDX | Becton, Dickinson and Company | 6.3% | 6.9% |
BDXA | Becton, Dickinson and Company | 6.3% | 6.9% |
BDXB | Becton, Dickinson and Company | 6.3% | 6.9% |
MOH | Molina Healthcare, Inc. | 6.2% | 21% |
EHC | Encompass Health Corporation | 6.1% | 11.9% |
RVTY | Revvity, Inc. | 6% | 2% |
WAT | Waters Corporation | 5.7% | 4% |
WBA | Walgreens Boots Alliance, Inc. | 5.6% | 6% |
CVS | CVS Health Corporation | 5.3% | 6.6% |
HLN | Haleon plc | 5.2% | 0.8% |
ABC | AmerisourceBergen Corporation | 5.1% | 14.7% |
COR | Cencora | 5.1% | 14.7% |
NVO | Novo Nordisk A/S | 5.1% | 21.4% |
MDT | Medtronic plc | 4.9% | 5.2% |
DOCS | Doximity, Inc. | 4.6% | 20.4% |
DHR | Danaher Corporation | 4.3% | -15.6% |
BIIB | Biogen Inc. | 4.2% | -2.5% |
VRTX | Vertex Pharmaceuticals Incorporated | 4.1% | 11.6% |
JAZZ | Jazz Pharmaceuticals plc | 4% | 8.5% |
MMSI | Merit Medical Systems, Inc. | 4% | 7.8% |
IQV | IQVIA Holdings Inc. | 3.9% | 4.3% |
TEVA | Teva Pharmaceutical Industries Limited | 3.9% | 12.5% |
UNH | UnitedHealth Group Incorporated | 3.6% | 10.3% |
ANTM | Elevance Health Inc. | 3.6% | 5.4% |
ELV | Elevance Health Inc. | 3.6% | 5.4% |
UTHR | United Therapeutics Corporation | 3.6% | 22.9% |
TFX | Teleflex Incorporated | 3.4% | 2.4% |
UHS | Universal Health Services, Inc. | 3.3% | 11.2% |
GILD | Gilead Sciences, Inc. | 3.2% | 7% |
COO | The Cooper Companies, Inc. | 2.9% | 7.8% |
ENSG | The Ensign Group, Inc. | 2.9% | 15% |
TAK | Takeda Pharmaceutical Company Limited | 2.6% | 12.7% |
BSX | Boston Scientific Corporation | 2.4% | 19.3% |
BRKR | Bruker Corporation | 2.4% | 16.4% |
VEEV | Veeva Systems Inc. | 2.4% | 14.6% |
ABT | Abbott Laboratories | 2.2% | 4.9% |
AMGN | Amgen Inc. | 2.2% | 23.2% |
QGEN | Qiagen N.V. | 2.2% | 5.5% |
BIO | Bio-Rad Laboratories, Inc. | 2% | 2.8% |
ATR | AptarGroup, Inc. | 2% | 1.8% |
TMO | Thermo Fisher Scientific Inc. | 1.9% | 0.2% |
LLY | Eli Lilly and Company | 1.9% | 20.4% |
HUM | Humana Inc. | 1.8% | 11.3% |
JNJ | Johnson & Johnson | 1.7% | 5.2% |
CHE | Chemed Corporation | 1.7% | 7.4% |
SYK | Stryker Corporation | 1.7% | 11.9% |
RPRX | Royalty Pharma plc | 1.6% | 5.3% |
ISRG | Intuitive Surgical, Inc. | 1.4% | 16.9% |
BMY | Bristol-Myers Squibb Company | 1.3% | 8.4% |
IDXX | IDEXX Laboratories, Inc. | 1.1% | 6.6% |
TEM | Tempus AI, Inc. | 1.1% | 33% |
GEHC | GE HealthCare Technologies Inc. | 1% | 0.9% |
DVA | DaVita Inc. | 0.9% | 4.6% |
CRL | Charles River Laboratories International, Inc. | 0.8% | -1.6% |
TECH | Bio-Techne Corporation | 0.6% | 4.5% |
EW | Edwards Lifesciences Corporation | 0.5% | -8.5% |
MEDP | Medpace Holdings, Inc. | 0.4% | 8.3% |
SOLV | Solventum Corporation | 0.4% | 1.4% |
AZN | AstraZeneca PLC | 0.4% | 18% |
PKI | PerkinElmer, Inc. | - | -42.3% |
FMS | Fresenius Medical Care AG & Co. KGaA | -0.1% | -3.6% |
A | Agilent Technologies, Inc. | -0.4% | -5.6% |
DGX | Quest Diagnostics Incorporated | -0.5% | 8.4% |
ZTS | Zoetis Inc. | -0.7% | 11% |
GKOS | Glaukos Corporation | -0.7% | 23.9% |
STE | STERIS plc | -0.9% | -1% |
LH | Laboratory Corporation of America Holdings | -1.2% | 7.4% |
HCA | HCA Healthcare, Inc. | -1.2% | 7.9% |
BLCO | Bausch + Lomb Corporation | -1.3% | 18.8% |
GMED | Globus Medical, Inc. | -1.4% | 63.1% |
THC | Tenet Healthcare Corporation | -1.5% | 1.1% |
ABBV | AbbVie Inc. | -1.6% | 3.8% |
GRFS | Grifols, S.A. | -1.7% | 7.8% |
RDNT | RadNet, Inc. | -1.8% | 14.7% |
PEN | Penumbra, Inc. | -1.9% | 11.1% |
LNTH | Lantheus Holdings, Inc. | -2% | 18.4% |
MTD | Mettler-Toledo International Inc. | -2.1% | 1.3% |
MRK | Merck & Co., Inc. | -2.3% | 4.4% |
ABMD | Abiomed, Inc. | -2.5% | 7.2% |
EXAS | Exact Sciences Corporation | -3% | 12.8% |
PHG | Koninklijke Philips N.V. | -3.7% | -2.1% |
RCM | R1 RCM Inc. | -4.1% | 14.7% |
ILMN | Illumina, Inc. | -4.1% | -3.5% |
RDY | Dr. Reddy's Laboratories Limited | -4.3% | 16.5% |
DXCM | DexCom, Inc. | -4.5% | 2% |
VTRS | Viatris Inc. | -4.6% | -5.2% |
ALC | Alcon Inc. | -4.8% | 5.4% |
HSIC | Henry Schein, Inc. | -5.1% | 0.4% |
CTLT | Catalent, Inc. | -6% | 4.2% |
HOLX | Hologic, Inc. | -6.8% | 4.5% |
ALGN | Align Technology, Inc. | -7.4% | 1.8% |
ZBH | Zimmer Biomet Holdings, Inc. | -8.6% | 4% |
GSK | GSK plc | -8.6% | -1.7% |
INSP | Inspire Medical Systems, Inc. | -8.7% | 32.5% |
INSM | Insmed Incorporated | -9.6% | 18.2% |
BGNE | BeiGene, Ltd. | -9.7% | 28.2% |
ICLR | ICON Public Limited Company | -10.2% | -1.2% |
SGEN | Seagen Inc. | -11% | 27.1% |
NBIX | Neurocrine Biosciences, Inc. | -11.5% | 24.7% |
CAH | Cardinal Health, Inc. | -12.6% | -4.5% |
ELAN | Elanco Animal Health Incorporated | -12.7% | -3.6% |
BPMC | Blueprint Medicines Corporation | -13.4% | 126.6% |
RXDX | Prometheus Biosciences, Inc. | -13.5% | -71.8% |
ALNY | Alnylam Pharmaceuticals, Inc. | -21.4% | -33.3% |
SGFY | Signify Health, Inc. | -24.4% | 11.9% |
BAX | Baxter International Inc. | -27% | -27.2% |
PODD | Insulet Corporation | -27.1% | -13.9% |
EXEL | Exelixis, Inc. | -27.6% | 1.3% |
ARGX | argenx SE | -28.3% | 73.8% |
LEGN | Legend Biotech Corporation | -28.5% | 66.9% |
CERE | Cerevel Therapeutics Holdings, Inc. | -100% | - |
KRTX | Karuna Therapeutics, Inc. | - | -100% |
NUVL | Nuvalent, Inc. | - | - |
PCVX | Vaxcyte, Inc. | - | - |
RVMD | Revolution Medicines, Inc. | - | - |
SMMT | Summit Therapeutics Inc. | - | - |
VKTX | Viking Therapeutics, Inc. | - | - |
ROIV | Roivant Sciences Ltd. | - | - |
